Press release
Global Animal Biotechnology Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Heska Corporation, Indian Immunologicals Ltd.
Animal Biotechnology Market
Get Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/6555
➤actionable insights
● Production capacity in animal biotechnology has surged, with global vaccine manufacturing facilities increasing output by 18% in 2024, driven by rising demand for recombinant vaccines across veterinary applications.
● Pricing strategies have seen gradual optimization, with therapeutic peptides for livestock maintaining average prices between USD 150-200 per dose in Q1 2025, reflecting a stabilization trend post-pandemic.
● Exports of biotech-derived animal health products from Asia Pacific countries, particularly India and China, grew by an estimated 11% year-on-year in 2024, signaling widening market opportunities internationally.
● Import volumes in North America for genetically engineered diagnostics witnessed a 14% rise in 2025, mainly attributed to increased demand for rapid pathogen detection technologies in companion animals.
● Use cases expanded beyond traditional livestock to include aquaculture and exotic animal care, with over 30% of biotech innovations in 2025 targeting improved feed efficiency and disease resistance.
❖Market segment and regional coverage
○ Comprehensive Segmentation and Classification of the Report:
» By Product: Vaccines, Diagnostics, Recombinant Therapeutics, Feed Additives, and Others
» By Application: Livestock, Companion Animals, Aquaculture, Research, and Others
» By Technology: Genetic Engineering, Tissue Culture, Molecular Diagnostics, and Others
○ Regional and Country Analysis:
» North America: U.S. and Canada
» Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
» Europe: Germany, U.K., Spain, France, Italy, Benelux, Denmark, Norway, Sweden, Russia, and Rest of Europe
» Asia Pacific: China, Taiwan, India, Japan, South Korea, Indonesia, Malaysia, Philippines, Singapore, Australia, and Rest of Asia Pacific
» Middle East & Africa: Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates, Israel, South Africa, North Africa, Central Africa, and Rest of MEA
✔Key players
» Heska Corporation, Indian Immunologicals Ltd., HESTER BIOSCIENCES LIMITED, Zoetis Inc., Boehringer Ingelheim International GmbH, Biogénesis Bagó, Merck & Co., Inc., Virbac, Elanco, Cadila Pharma, Thermo Fisher Scientific Inc., Idexx Laboratories, Randox Laboratories Ltd., Gold Standard Diagnostics, Bionote USA Inc., Meiji Holdings Co., Ltd., Kemin Industries, Inc., Pfizer Inc.
» Competitive strategies include Zoetis Inc.'s acquisition of genomics firms to diversify product portfolios and Merck & Co., Inc.'s expansion into emerging markets via local partnerships, yielding a 12% revenue uplift in 2024.
» Indian Immunologicals Ltd. focused on scaling vaccine production capacity, achieving a 20% production increase in 2025, which reinforced their market position in Asia Pacific.
Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/6555
➤Growth factors
✓ Rising prevalence of zoonotic diseases and need for advanced diagnostic tools are primary market drivers evidencing a 15% annual increase in biotech diagnostics adoption globally in 2024.
✓ Government initiatives supporting livestock health through biotech innovation, such as subsidies for recombinant vaccine development in key regions like North America and Europe, propelled business growth.
✓ Increasing consumer demand for sustainable animal protein sources stimulates research investment, reflected by a 10% growth in funding for feed additive biotech solutions in 2025
❖ Market trends
⇨ Genetic editing technologies like CRISPR are increasingly leveraged in animal biotechnology, with pilot projects in 2024 demonstrating up to 25% improved disease resistance in cattle populations.
⇨ Digital integration with biotechnology, combining AI with molecular diagnostics, accelerated market opportunities, accounting for a 22% increase in market revenue from smart diagnostic devices in 2025.
⇨ Collaborative ventures between biotech firms and academic institutions expanded translational research activity by 18% in 2024, fostering innovation and faster product development cycles.
✒Key takeaways
→ The Vaccines segment dominates product categories, accounting for broad application in livestock and companion animals, primarily driven by recombinant and mRNA-based vaccines.
→ Companion Animals under the Application segment show rapid business growth due to rising pet ownership and advanced diagnostics.
→ Genetic Engineering leads technology adoption, enabling precise biotech interventions and accelerating market scope expansion.
→ North America is a critical hub for biotech innovation with concentrated R&D efforts and infrastructure investments.
→ Asia Pacific emerges as a key growth region due to expanding production capacities and export volumes.
→ Europe maintains strong regulatory frameworks that foster innovation while addressing market restraints effectively.
To Purchase This Premium Report, Click Here (Discount of Up to 25%): https://www.coherentmarketinsights.com/insight/buy-now/6555
❓ Frequently Asked Questions
1. Who are the dominant players in the Global Animal Biotechnology market?
The leading companies include Heska Corporation, Indian Immunologicals Ltd., Zoetis Inc., Merck & Co., Inc., and Thermo Fisher Scientific Inc., recognized for extensive portfolios and innovative market growth strategies.
2. What will be the size of the Global Animal Biotechnology market in the coming years?
The market size is projected to grow from USD 31.55 billion in 2025 to USD 58.05 billion by 2032, at a CAGR of 9.1%, reflecting robust expansion driven by technological advancements.
3. Which end users' industry has the largest growth opportunity?
Livestock application holds significant growth opportunities due to rising demand for disease-resistant breeds and improved productivity, supported by advancements in vaccines and feed additives.
4. How will market development trends evolve over the next five years?
Trends indicate increased adoption of gene-editing techniques, AI-powered diagnostics, and collaborative R&D ventures, accelerating product innovation and expanding market revenue streams.
5. What is the nature of the competitive landscape and challenges in the Global Animal Biotechnology market?
Competition remains intense with emphasis on capacity expansion and technology integration; however, challenges such as regulatory compliance and high R&D costs persist but are being managed through partnerships.
Author of this Marketing PR:
Ravina Pandya, PR Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. With an MBA in E-commerce, she has an expertise in SEO-optimized content that resonates with industry professionals.
📞 Contact Us:
Mr. Shah
Coherent Market Insights Pvt. Ltd,
U.S.: + 12524771362
U.K.: +442039578553
AUS: +61-2-4786-0457
INDIA: +91-848-285-0837
About CMI:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Animal Biotechnology Market Exclusive Report with Detailed Study Analysis By 2025-2032 | Heska Corporation, Indian Immunologicals Ltd. here
News-ID: 4099793 • Views: …
More Releases from Coherent Market Insights Pvt. Ltd.
Pneumococcal Vaccines Market is evolving rapidly Through 2025 To 2032 | Pfizer I …
The pneumococcal vaccines market is a critical component of global public health initiatives aimed at combating Streptococcus pneumoniae infections, which cause severe illnesses such as pneumonia, meningitis, and septicemia. Advances in vaccine technology and increasing awareness about pneumococcal diseases have contributed to the industry's steady expansion. Healthcare infrastructure enhancements and government immunization programs worldwide further support the uptake of pneumococcal vaccines across various age groups. The Global Pneumococcal Vaccines Market…
Point Of Care Diagnostics Market Set to Soar by 2032 with Emerging Innovations a …
The Point Of Care Diagnostics industry continues to gain significant traction as rapid and accurate diagnostic solutions become increasingly critical across healthcare settings worldwide. Innovations in portable and easy-to-use devices that enable testing near the patient have driven broader adoption, fostering improvements in clinical outcomes and operational efficiency. The industry's capacity to reduce diagnosis time and facilitate immediate clinical decision-making is reshaping healthcare delivery, particularly in emergency care, chronic disease…
![Alzheimers Drugs Market [2025-2032] - Exclusive Report Featuring In-Depth Analysis and Leading Key Players AbbVie, Inc., Teva Pharmaceuticals Ltd.](https://cdn.open-pr.com/L/7/L725849991_g.jpg)
Alzheimers Drugs Market [2025-2032] - Exclusive Report Featuring In-Depth Analys …
The Alzheimer's Drugs Market is witnessing transformative growth driven by ongoing advancements in pharmaceutical research and an increasing global aging population. As life expectancy rises, the incidence of Alzheimer's disease is escalating, necessitating innovative drug development and diversified treatment options. This evolving landscape is marked by intensive clinical trials and expanding therapeutic pipelines. The Global Alzheimer's Drugs Market size is estimated to be valued at USD 5.64 Billion in 2025…
Electronic Health Records Market Booming Amid Surge in Digital Healthcare Adopti …
The Electronic Health Records (EHR) industry continues to reshape healthcare delivery by enabling seamless patient data management and enhancing clinical workflows. Over the past few years, integration of advanced technologies such as AI and cloud computing has accelerated the adoption of EHR systems, driving considerable innovation across healthcare providers and payers. The market's increasing role in streamlining healthcare services, reducing medical errors, and enabling regulatory compliance underscores its strategic importance…
More Releases for Animal
Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled…
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market.
Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708
Farm Animals and Companion Animals are the…
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of…
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market
Developing Regions to Overpower Developed Ones With Regard to Demand
The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their…
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,…
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report…
